<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02361476</url>
  </required_header>
  <id_info>
    <org_study_id>H - 2 - 2014 - 072</org_study_id>
    <nct_id>NCT02361476</nct_id>
  </id_info>
  <brief_title>Does Intraoperative Clonidine Reduce Post Operative Agitation in Children?</brief_title>
  <official_title>Does Intraoperative Clonidine Reduce Post Operative Agitation in Children Anaesthetised With Sevoflurane? A RCT Including Pharmacokinetic Investigation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clonidine is widely used off-label in children for several indications. Clonidine is used for
      treatment and/or prevention of postoperative agitation in children anaesthetised with
      Sevoflurane. The investigators don´t have solid evidence for the effect and the investigators
      don´t have data for characterization of the pharmacokinetic profile among age-groups for
      children 1-6 years.

      In this study the investigators want to investigate if IV Clonidine administered at the end
      of surgery can prevent/reduce postoperative agitation. Secondary outcomes include
      measurements of postoperative pain relief and adverse effects, including a 30-day follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:

      Clonidine is widely used off-label in children for several indications such as treatment
      and/or prevention of postoperative agitation when anaesthetised with Sevoflurane. However,
      the current level of evidence in support of Clonidine treatment for postoperative agitation
      in children remains limited. In addition, the pharmacokinetic profile of intravenous
      Clonidine in children is not well characterized for age-groups.

      METHODS/DESIGN:

      In this prospective multicentre double-blinded randomized clinical trial, the investigators
      aim to investigate the impact of intravenous (IV) Clonidine administered at the end of
      surgery, on the incidence and degree of postoperative agitation. Children will be assigned to
      either the intervention or the placebo group. The allocation will be carried out centrally
      and stratified based on age and trial-site, with152 patients allocated to each group. In the
      intervention group, 3 micrograms per kg of IV clonidine is administered approximately 20
      minutes before the expected completion of the surgery (as assessed by the surgeon). In the
      control group; Saline (placebo) is injected in equal quantity during surgery at the same
      time. The drugs are concealed in identical blinded ampoules.

      The primary outcome is postoperative agitation measured on the Watcha scale. Secondary
      outcomes include measurements of postoperative pain relief and adverse effects, including
      30-day follow-up.

      Twenty of the patients age 1-2 years and twenty age &gt;2 years, with a peripheral venous access
      in place, will be allocated to drug assay sampling; enabling a compartmental PK analysis
      based on age group, using non-linear mixed effects models.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Agitation</measure>
    <time_frame>1 day</time_frame>
    <description>Measured by Watchae Scale (score 1-4), scores 1-2 = no agitation and scores 3-4 = agitated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fentanyl and Morphine Requirements</measure>
    <time_frame>Recorded during the stay in the postoperative recovery room</time_frame>
    <description>Amount used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Assessment</measure>
    <time_frame>recovery room - hours</time_frame>
    <description>Pain score used:
FLACC score = Face, Legs, Activity, Cry, Consolability Score ranges from 0 to 10 (severity increases with increasing score) Pain is FLACC score more than 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First Administration of Fentanyl or Morphine</measure>
    <time_frame>recovery room</time_frame>
    <description>Time to administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>from intervention to discharge from the recovery room</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">379</enrollment>
  <condition>Psychomotor Agitation</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clonidine : injection og 3 micg/kg IV during the operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo : injection og equal amount of NaCl IV during the operation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <description>Injection - during surgery</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>catapresan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Injection - during surgery</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>NaCl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled for surgery with Sevoflurane as the choice of anesthesia.

        Exclusion Criteria:

          -  ASA classification &gt;2

          -  Premedication with Clonidine

          -  Ex-premature (born before week 37+0 AND &lt;60 weeks old)

          -  Intubated before anaesthesia and/or no plans for extubation after anaesthesia.

          -  Critical illness with haemodynamic instability.

          -  Active bleeding.

          -  Cancer.

          -  Cardiac diseases including arrhythmias.

          -  Malignant hyperthermia.

          -  Mental retardation.

          -  Neurological illness with agitation-like symptoms.

          -  Weight &gt;50 kg.

          -  Allergy to Clonidine.

          -  Patients treated with methylphenidate / Concerta.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steen Henneberg, MD, DMSc</last_name>
    <role>Study Director</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>Zealand</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Køge Sygehus, Anæstesiologisk Afdeling</name>
      <address>
        <city>Køge</city>
        <zip>4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Anæstesiologisk afdeling, Vejle Sygehus</name>
      <address>
        <city>Vejle</city>
        <zip>7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Pickard A, Davies P, Birnie K, Beringer R. Systematic review and meta-analysis of the effect of intraoperative α₂-adrenergic agonists on postoperative behaviour in children. Br J Anaesth. 2014 Jun;112(6):982-90. doi: 10.1093/bja/aeu093. Epub 2014 Apr 11. Review.</citation>
    <PMID>24727829</PMID>
  </reference>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>February 1, 2015</study_first_submitted>
  <study_first_submitted_qc>February 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2015</study_first_posted>
  <results_first_submitted>November 22, 2017</results_first_submitted>
  <results_first_submitted_qc>September 11, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 11, 2019</results_first_posted>
  <last_update_submitted>September 11, 2018</last_update_submitted>
  <last_update_submitted_qc>September 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Mogens Ydemann</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Anaesthesia</keyword>
  <keyword>Children</keyword>
  <keyword>Clonidine</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>Postoperative agitation</keyword>
  <keyword>Prevention</keyword>
  <keyword>Pharmacokinetics</keyword>
  <keyword>Safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clonidine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intervention</title>
          <description>Clonidine : injection og 3 micg/kg IV during the operation.
Clonidine: Injection - during surgery</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo : injection og equal amount of NaCl IV during the operation.
Placebo: Injection - during surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="191"/>
                <participants group_id="P2" count="188"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="191"/>
                <participants group_id="P2" count="188"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intervention</title>
          <description>Clonidine : injection og 3 micg/kg IV during the operation.
Clonidine: Injection - during surgery</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo : injection og equal amount of NaCl IV during the operation.
Placebo: Injection - during surgery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="191"/>
            <count group_id="B2" value="188"/>
            <count group_id="B3" value="379"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt; 2 years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="191"/>
                    <count group_id="B2" value="188"/>
                    <count group_id="B3" value="379"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;/= 2 years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="191"/>
                    <count group_id="B2" value="188"/>
                    <count group_id="B3" value="379"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="145"/>
                    <measurement group_id="B2" value="145"/>
                    <measurement group_id="B3" value="290"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="191"/>
                    <count group_id="B2" value="188"/>
                    <count group_id="B3" value="379"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="154"/>
                    <measurement group_id="B2" value="150"/>
                    <measurement group_id="B3" value="304"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Denmark</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="191"/>
                    <count group_id="B2" value="188"/>
                    <count group_id="B3" value="379"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="191"/>
                    <measurement group_id="B2" value="188"/>
                    <measurement group_id="B3" value="379"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Agitation</title>
        <description>Measured by Watchae Scale (score 1-4), scores 1-2 = no agitation and scores 3-4 = agitated</description>
        <time_frame>1 day</time_frame>
        <population>9 were excluded in the primary outcome due to missing data points</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Clonidine : injection og 3 micg/kg IV during the operation.
Clonidine: Injection - during surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo : injection og equal amount of NaCl IV during the operation.
Placebo: Injection - during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Agitation</title>
          <description>Measured by Watchae Scale (score 1-4), scores 1-2 = no agitation and scores 3-4 = agitated</description>
          <population>9 were excluded in the primary outcome due to missing data points</population>
          <units>participants with agitation</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="187"/>
                <count group_id="O2" value="183"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fentanyl and Morphine Requirements</title>
        <description>Amount used</description>
        <time_frame>Recorded during the stay in the postoperative recovery room</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Clonidine : injection og 3 micg/kg IV during the operation.
Clonidine: Injection - during surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo : injection og equal amount of NaCl IV during the operation.
Placebo: Injection - during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Fentanyl and Morphine Requirements</title>
          <description>Amount used</description>
          <units>mg morphine equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="191"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.46" spread="0.94"/>
                    <measurement group_id="O2" value="0.7" spread="1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Assessment</title>
        <description>Pain score used:
FLACC score = Face, Legs, Activity, Cry, Consolability Score ranges from 0 to 10 (severity increases with increasing score) Pain is FLACC score more than 3</description>
        <time_frame>recovery room - hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Clonidine : injection og 3 micg/kg IV during the operation.
Clonidine: Injection - during surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo : injection og equal amount of NaCl IV during the operation.
Placebo: Injection - during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Assessment</title>
          <description>Pain score used:
FLACC score = Face, Legs, Activity, Cry, Consolability Score ranges from 0 to 10 (severity increases with increasing score) Pain is FLACC score more than 3</description>
          <units>Pain Score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="191"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.57" spread="2.62"/>
                    <measurement group_id="O2" value="2.45" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Administration of Fentanyl or Morphine</title>
        <description>Time to administration</description>
        <time_frame>recovery room</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Clonidine : injection og 3 micg/kg IV during the operation.
Clonidine: Injection - during surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo : injection og equal amount of NaCl IV during the operation.
Placebo: Injection - during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>First Administration of Fentanyl or Morphine</title>
          <description>Time to administration</description>
          <units>MEDIAN time (min) to administration</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="191"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105" spread="57"/>
                    <measurement group_id="O2" value="60" spread="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Events</title>
        <time_frame>from intervention to discharge from the recovery room</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Clonidine : injection og 3 micg/kg IV during the operation.
Clonidine: Injection - during surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo : injection og equal amount of NaCl IV during the operation.
Placebo: Injection - during surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="191"/>
                <count group_id="O2" value="188"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>adverse events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>serious adverse events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Treated for low blood pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Intervention</title>
          <description>Clonidine : injection og 3 micg/kg IV during the operation.
Clonidine: Injection - during surgery</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo : injection og equal amount of NaCl IV during the operation.
Placebo: Injection - during surgery</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>PONV</sub_title>
                <description>events leading to admission</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Late arrival in the postoperative care unit</sub_title>
                <description>events leading to admission</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Pale and not drinking and eating</sub_title>
                <description>events leading to admission</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Re-bleeding</sub_title>
                <description>events leading to admission</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Opioid-related side-effects</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Laryngeal spasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
              <event>
                <sub_title>Prolonged anaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="188"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Mogens Ydemann, MD</name_or_title>
      <organization>Rigshospitalet</organization>
      <phone>+45 35455620</phone>
      <email>mogens@ydemann.dk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

